Harvard Bioscience Announces Fourth Quarter Earnings Call
Harvard Bioscience, Inc. (NASDAQ: HBIO) is set to release its financial results for the quarter ending December 31, 2024, on March 12, 2025. The announcement will come before the market opens, with a follow-up conference call scheduled for 8:00 a.m. Eastern Time on the same day.
How to Participate in the Earnings Call
For those interested in joining the call and engaging with the management team, advance registration is required. Participants will receive unique dial-in numbers and a PIN upon registration. This provides an excellent opportunity to gain insights directly from company executives and ask pertinent questions.
Webcast for Audio-Only Participation
In addition to the conference call, an audio-only webcast will be available for participants who prefer an online format. This webcast can be accessed via the Investor Relations section of Harvard Bioscience's official website. Both formats aim to increase transparency and accessibility for stakeholders, ensuring that everyone can stay informed about the company's performance.
Financial Updates and Presentations
During the call, Harvard Bioscience will present key financial information, including an earnings release and a detailed slide presentation. These resources will aid in understanding the company’s performance during the identified quarter, emphasizing financial metrics that are vital for investors.
About Harvard Bioscience
Harvard Bioscience, Inc. stands out as a premier developer and manufacturer of technologies that facilitate major advancements in life science applications. Catering to a diverse clientele that includes prestigious academic institutions, government labs, and leading pharmaceutical, biotechnology, and contract research organizations, the company holds a strategic position in the global market.
Global Presence and Customer Base
Operational globally, Harvard Bioscience extends its reach across the United States, Europe, and China. The company employs a dual channel sales strategy, leveraging both direct sales and distribution partners to enhance customer engagement and support. This approach ensures that their groundbreaking solutions are readily available to researchers and scientists worldwide.
Social Responsibility and Innovation
Not only focused on sales and profit, Harvard Bioscience actively participates in initiatives that promote social responsibility and community engagement. By supporting educational programs, the company invests in the future of science and its impact on society. Innovation remains at the forefront of Harvard Bioscience’s mission, as it seeks to develop leading-edge technologies that meet the evolving needs of the life sciences sector.
Company Contact Information
For direct inquiries or more information about the upcoming earnings call, you can contact:
Jennifer Cote
Chief Financial Officer
Phone: (508) 893-3120
Investors Relations
If you need further assistance regarding investor relations, please reach out to:
Three Part Advisors
Sandy Martin
Email: HBIO@threepa.com
Phone: (214) 616-2207
Frequently Asked Questions
1. When is the earnings call for Harvard Bioscience?
The earnings call is scheduled for March 12, 2025, at 8:00 a.m. Eastern Time.
2. How can I participate in the earnings call?
To participate, you need to register in advance to receive the dial-in numbers and PIN.
3. Will a webcast be available for the earnings call?
Yes, an audio-only webcast will be available for those who prefer that format.
4. What information will be provided during the earnings call?
The call will include financial results for the quarter, along with a slide presentation.
5. Where can I find more information about Harvard Bioscience?
For more details, you can visit Harvard Bioscience's official website.
